Chiara Elli1, Alessio Novella1, Alessandro Nobili1, Aladar Ianes2, Luca Pasina3. 1. Laboratory of Clinical Pharmacology and Appropriateness of Drug Prescription, Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri, 2, 20156, Milan, Italy. 2. Medical Direction, Korian Italy, Milan, Italy. 3. Laboratory of Clinical Pharmacology and Appropriateness of Drug Prescription, Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri, 2, 20156, Milan, Italy. luca.pasina@marionegri.it.
Abstract
PURPOSE: Some medications can cause anemia through their effect on gastrointestinal function, such as proton pump inhibitors and H2-antagonists, and on the risk of bleeding, such as anticoagulants and antiplatelet agents. The main aim of this study is to evaluate how anemia is related with the most commonly used drugs in a large sample of NH residents. METHODS: This retrospective cross-sectional multicenter study was conducted in a sample of Italian long-term care NHs distributed throughout the country. RESULTS: In all, 2602 NH residents recruited from 27 Italian long-term NHs (mean age ± SD: 88.4 ± 8.5) and 441 (16.9%) had a diagnosis of anemia. The unadjusted model showed a significant relation with PPI (OR 1.71, 95% CI 1.39-2.11, p < 0.0001). This relation was maintained in the model adjusted for age, sex, CKD, atrophic gastritis, peptic ulcer and rheumatic disease (OR 1.61, 95% CI 1.31-1.99, p < 0.0001). PPI users were also at higher risk of being treated with antianemic drugs-iron supplements, folate, vitamin B12 and erythropoietin (OR 2.03, 95% CI 1.67-2.48, p < 0.0001)-even if they did not have anemia (OR 1.94, 95% CI 1.55-2.42, p < 0.0001). CONCLUSION: Proton pump inhibitors are associated with anemia in NH residents. PPIs are also related with an increased probability of receiving drugs to treat anemia, such as iron supplements, folate or cyanocobalamin and erythropoietin, as the effect of a prescribing cascade. Optimization of PPI prescription is needed to avoid adverse events and promote rational drug prescription.
PURPOSE: Some medications can cause anemia through their effect on gastrointestinal function, such as proton pump inhibitors and H2-antagonists, and on the risk of bleeding, such as anticoagulants and antiplatelet agents. The main aim of this study is to evaluate how anemia is related with the most commonly used drugs in a large sample of NH residents. METHODS: This retrospective cross-sectional multicenter study was conducted in a sample of Italian long-term care NHs distributed throughout the country. RESULTS: In all, 2602 NH residents recruited from 27 Italian long-term NHs (mean age ± SD: 88.4 ± 8.5) and 441 (16.9%) had a diagnosis of anemia. The unadjusted model showed a significant relation with PPI (OR 1.71, 95% CI 1.39-2.11, p < 0.0001). This relation was maintained in the model adjusted for age, sex, CKD, atrophic gastritis, peptic ulcer and rheumatic disease (OR 1.61, 95% CI 1.31-1.99, p < 0.0001). PPI users were also at higher risk of being treated with antianemic drugs-iron supplements, folate, vitamin B12 and erythropoietin (OR 2.03, 95% CI 1.67-2.48, p < 0.0001)-even if they did not have anemia (OR 1.94, 95% CI 1.55-2.42, p < 0.0001). CONCLUSION: Proton pump inhibitors are associated with anemia in NH residents. PPIs are also related with an increased probability of receiving drugs to treat anemia, such as iron supplements, folate or cyanocobalamin and erythropoietin, as the effect of a prescribing cascade. Optimization of PPI prescription is needed to avoid adverse events and promote rational drug prescription.
Authors: Tuen Ching Chan; Desmond Yat Hin Yap; Yat Fung Shea; James Ka Hay Luk; Felix Hon Wai Chan; Leung Wing Chu Journal: Geriatr Gerontol Int Date: 2012-09-19 Impact factor: 2.730
Authors: Francesco Landi; Andrea Russo; Paola Danese; Rosa Liperoti; Christian Barillaro; Roberto Bernabei; Graziano Onder Journal: J Am Med Dir Assoc Date: 2007-05-07 Impact factor: 4.669
Authors: Bruce Robinson; Andrew S Artz; Bruce Culleton; Cathy Critchlow; Angela Sciarra; Paul Audhya Journal: J Am Geriatr Soc Date: 2007-08-28 Impact factor: 5.562
Authors: T S Dharmarajan; Anna Pankratov; Evelyn Morris; Saima Qurashi; Gregory Law; Sunila Phillips; Praveen Jaspal; Indira Donepudi; Edward P Norkus Journal: J Am Med Dir Assoc Date: 2008-05-01 Impact factor: 4.669
Authors: Valerie K Sabol; Barbara Resnick; Elizabeth Galik; Ann Gruber-Baldini; Patricia Gonce Morton; Gregory E Hicks Journal: J Am Acad Nurse Pract Date: 2010-01